Sign In
Buy FLGT
$18.14
-0.560 (-2.99%)
At Close: Jun 03, 2026
The company is offering end-to-end processing, analysis and reporting for its COVID-19 tests through its BSL-2, CLIA-certified lab in Temple City, California. In addition, the EUA allows for the test
Fulgent Genetics, Inc. (FLGT) Q1 2020 Earnings Call Transcript
03:00pm, Tuesday, 05'th May 2020
On the call today, we have Ming Hsieh, Chief Executive Officer, Paul Kim, Chief Financial Officer, and Brandon Perthuis, Chief Commercial Officer. The company's press release discussing its financial
Fulgent Genetics Reports First Quarter 2020 Financial Results | MarketScreener
08:06pm, Monday, 04'th May 2020Fulgent Genetics Reports First Quarter 2020 Financial Results
08:05pm, Monday, 04'th May 2020
First Quarter 2020 Results: Revenue totals $7.8 million, growing 44% year over yearBillable tests delivered total 13,163, growing 75% year over yearGross Margin improves.
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Quest Diagnostics (DGX) Receives a Hold from Credit Suisse
07:42pm, Friday, 24'th Apr 2020
Credit Suisse analyst Erin Wright maintained a Hold rating on Quest Diagnostics (DGX) yesterday and set a price target of $100.00. The company's shares
Quest Diagnostics (DGX) Receives a Hold from Credit Suisse
07:42pm, Friday, 24'th Apr 2020
Credit Suisse analyst
Erin Wright
maintained a
Hold
rating on Quest Diagnostics (
DGX
–
Research Report
) yesterday and set a price target of
$100.00
. The company’s shares closed last Friday at $
Credit Suisse Maintains a Hold Rating on Covetrus (CVET)
01:16pm, Thursday, 23'rd Apr 2020
In a report released today, Erin Wright from Credit Suisse maintained a Hold rating on Covetrus (CVET), with a price target of $10.00. The company's
Credit Suisse Maintains a Hold Rating on Covetrus (CVET)
01:16pm, Thursday, 23'rd Apr 2020
In a report released today, Erin Wright from Credit Suisse maintained a Hold rating on Covetrus (CVET – Research Report),
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Path To Profitability
12:17pm, Thursday, 16'th Apr 2020
Fulgent Genetics, Inc.'s (NASDAQ:FLGT): Fulgent Genetics, Inc., together with its subsidiaries, provides genetic...
Fulgent Genetics to Announce First Quarter 2020 Financial Results on Monday May 4, 2020
12:01pm, Thursday, 09'th Apr 2020
The company’s Chairman and Chief Executive Officer Ming Hsieh, Chief Financial Officer Paul Kim and Chief Commercial Officer Brandon Perthuis will host a conference call for the investment community
Fulgent Genetics Provides Update on Testing for COVID-19
12:00pm, Thursday, 09'th Apr 2020
The company is currently accepting samples directly to its BSL-2 certified lab in Temple City, California, versus previously accepting extracted RNA samples through third party laboratories. With the
Edited Transcript of FLGT earnings conference call or presentation 10-Mar-20 8:30pm GMT
07:22am, Friday, 27'th Mar 2020
Q4 2019 Fulgent Genetics Inc Earnings Call
DOW, REGN among premarket gainers
01:22pm, Tuesday, 17'th Mar 2020
BioNTech SE (NASDAQ:BNTX) +55% on teaming up with Pfizer teams to develop COVID-19 vaccine.Co-Diagnostics (NASDAQ:CODX) +45% as FDA to allow states to authorize coronavirus tests.Neon Therapeutics (
